We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
Cap. Flow
+$74.9M
Cap. Flow %
13.41%
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643

Top Buys

Rank Stock Value
1
TGT icon
Target
TGT
+$3.2M
2
BA icon
Boeing
BA
+$2.64M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.42M
4
AMGN icon
Amgen
AMGN
+$2.03M
5
ELV icon
Elevance Health
ELV
+$1.97M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.64M
2
LMT icon
Lockheed Martin
LMT
+$2.31M
3
CI icon
Cigna
CI
+$2.21M
4
WFC icon
Wells Fargo
WFC
+$2.18M
5
PAYX icon
Paychex
PAYX
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 17.12%
2 Healthcare 15.64%
3 Consumer Discretionary 14.34%
4 Industrials 14.21%
5 Financials 12.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTLA icon
1701
Intellia Therapeutics
NTLA
$1.49B
– –
-13,258
Closed -$494K
NTNX icon
1702
Nutanix
NTNX
$15.4B
– –
-15,015
Closed -$390K
NTR icon
1703
Nutrien
NTR
$32.4B
– –
-3,219
Closed -$238K
NTST
1704
NETSTREIT Corp
NTST
$2.13B
– –
-11,388
Closed -$208K
NU icon
1705
Nu Holdings
NU
$70.2B
– –
-58,307
Closed -$278K
NVAX icon
1706
Novavax
NVAX
$1.23B
– –
-29,758
Closed -$206K
NVCR icon
1707
NovoCure
NVCR
$1.97B
– –
-3,995
Closed -$240K
NVGS icon
1708
Navigator Holdings
NVGS
$1.34B
– –
-12,563
Closed -$176K
NVRI icon
1709
Enviri
NVRI
$620M
– –
-24,702
Closed -$169K
NVT icon
1710
nVent Electric
NVT
$24.1B
– –
-14,841
Closed -$637K
NWG icon
1711
NatWest
NWG
$72.8B
– –
-16,215
Closed -$107K
OGS icon
1712
ONE Gas
OGS
$5.02B
– –
-6,684
Closed -$530K
OM icon
1713
Outset Medical
OM
$80.1M
– –
-980
Closed -$270K
ACH
1714
Accendra Health
ACH
$247M
– –
-18,233
Closed -$265K
ONON icon
1715
On Holding
ONON
$12.4B
– –
-12,672
Closed -$393K
ONTO icon
1716
Onto Innovation
ONTO
$13B
– –
-2,721
Closed -$239K
ORLA
1717
Orla Mining
ORLA
$3.56B
– –
-16,415
Closed -$78K
ORMP icon
1718
Oramed Pharmaceuticals
ORMP
$170M
– –
-151,620
Closed -$331K
OSPN icon
1719
OneSpan
OSPN
$562M
– –
-21,190
Closed -$371K
PAA icon
1720
Plains All American Pipeline
PAA
$17.1B
– –
-26,918
Closed -$336K
PAC icon
1721
Grupo Aeroportuario del Pacifico
PAC
$12.9B
– –
-1,041
Closed -$203K
PAGP icon
1722
Plains GP Holdings
PAGP
$5.16B
– –
-13,350
Closed -$175K
PAGS icon
1723
PagSeguro Digital
PAGS
$2.62B
– –
-71,876
Closed -$616K
PANL icon
1724
Pangaea Logistics
PANL
$488M
– –
-16,293
Closed -$95.6K
PAR icon
1725
PAR Technology
PAR
$682M
– –
-8,763
Closed -$298K
67 68
69
70 71

Similar funds

HW
Hancock Whitney Gulfport, Mississippi $5.75B AUM 24.3% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $5.76B AUM 22.07% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return
SAM
Scopus Asset Management New York $5.77B AUM 36.85% 1-Year Est. Return
PP
Peconic Partners New York $5.78B AUM 127.23% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

XTX Topco's Q2 2023 Portfolio in Review

As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.

XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.

  • XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
  • XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
  • XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
  • XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
  • XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
  • XTX Topco opened 778 new positions and closed 643 in Q2 2023.
  • XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.

Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.